Bovine Mastitis Market Size, Share, Competitive Landscape and Trend Analysis Report by Product, by Route of administration, by Application : Global Opportunity Analysis and Industry Forecast, 2021-2031

Bovine Mastitis Market Size, Outlook - 2031

The global bovine mastitis market was valued at $0.54 billion in 2021 and is projected to reach $1.01 billion by 2031, growing at a CAGR of 6.3% from 2022 to 2031. Bovine mastitis is an inflammatory response of the udder tissue in the mammary gland caused due to physical trauma or microorganism infections. It is considered the most common disease leading to economic loss in dairy industries due to reduced yield and poor quality of milk.

Market Dynamics

The increase in the prevalence of bovine mastitis and rise in awareness about bovine mastitis is expected to majorly drive the Bovine Mastitis Industry growth. For instance, according to an article published in 2020, by IntechOpen, a leading global publisher of Journals and Books within the fields of Science, Technology, and Medicine, the overall prevalence of subclinical mastitis in cows was 31.55%. The prevalence of subclinical mastitis was highest in 5–7 years of age group (38.50%). In addition, many key market players are focusing on R&D activities to develop drugs for bovine mastitis as the dairy animal population is increasing, which also contributes to the bovine mastitis market growth. The key factors such as environmental factors, pathogens, physical injury to the mammary region, and poor hygiene contribute for the increase in the prevalence of bovine mastitis.

Moreover, an increase in R&D activity for the development of advanced bovine mastitis treatment, product launches, and product approvals contributes to the growth of the Bovine Mastitis Industry. For instance, in October 2020, NovaQuest Capital Management L.L.C., an investment company, announced a $20 million peptide product development deal with Mileutis, an Israeli biotech company for the management, treatment, and prevention of bovine mastitis. Thus, the rise in R&D activities and the latest product approvals by regulating authorities contribute to the growth of the Bovine Mastitis Market Size.

The growing interest of manufacturers and developers in the development of bovine mastitis and the latest product launch drives the growth of the Bovine Mastitis Market Size. For instance, in February 2020, Ecolab Inc., the global leader in water, food safety, and health technologies and services, introduced Eco-Flex Teat Dip, an effective and affordable udder care solution for dairy cows that helps prevent infection, improve teat health, and support milk quality. In addition, combined manufacturers' efforts for developing footprints in emerging market contributes to the growth of the market.  In addition, an increase in demand for dairy products and a rise in government initiatives to provide healthcare services for animals, are expected to boost the market growth.

Segments Overview

By product, segment market is divided into antibiotics and others. Depending on the route of administration segment is classified into intramammary and systemic. According to end-user segment, the market is segmented into veterinary hospitals & clinics, and on-site treatment. The veterinary hospitals & clinics segment is further classified into mild cases, moderate cased and severe cases. The on-site treatment segment is further sub-segmented into mild cases, moderate cased and severe cases. By region, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, Turkey, and LAMEA).

Depending on the product, the antibiotics segment dominated the Bovine Mastitis Market Share in 2021, and this trend is expected to continue during the forecast period, owing to advancements in bovine mastitis treatment and increasing demand for antibiotics for treatment. However, the other segment is expected to witness considerable growth during the forecast period, due to an increase in demand for teat sealants and the latest product launch in the market.

Based on the route of administration, the systemic segment dominated the Bovine Mastitis Market Share in 2021, and this trend is expected to continue during the forecast period, owing to the increasing prevalence of bovine mastitis and the rise in animal welfare funding. However, the intramammary segment is expected to witness considerable growth during the forecast period, due to an increase in the prevalence of bovine mastitis and a rise in R&D activities for the development of advanced treatment.

By application, the on-site treatment segment dominated the Bovine Mastitis Market Share in 2021, and this trend is expected to continue during the forecast period, owing to a rise in the number of veterinarians and an increase in demand of advanced treatment. However, the veterinary hospitals & clinics segment is expected to witness considerable growth during the forecast period, due to an increase in the number of veterinary hospitals & clinics and a rise in healthcare expenditures.

Depending on the region, Asia-Pacific garnered the major share in the bovine mastitis market in 2021 and is expected to dominate the global market during the forecast period owing to the presence of well-established animal healthcare infrastructure, advancements in bovine mastitis, and the presence of dairy farms. However, LAMEA is expected to register significant growth, owing to an increase in product launches in the region, a rise in animal healthcare expenditures, and an increasing number of dairy farms.

Key Benefits for Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the Bovine Mastitis Market Forecast from 2021 to 2031 to identify the prevailing Bovine Mastitis Market Opportunity.
• Market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
• An in-depth analysis of the bovine mastitis market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the Bovine Mastitis Market Analysis of the regional as well as global bovine mastitis market trends, key players, market segments, application areas, and market growth strategies.

  Bovine Mastitis Market Report Highlights

Aspects	Details
Market Size By 2031	USD 1 billion
Growth Rate	CAGR of 6.3%
Forecast period	2021 - 2031
Report Pages	300
By Product	Antibiotics Other
By Route of administration	Intramammary Systemic
By Application	Veterinary Hospitals and Clinics Cases Mild Cases Moderate Cased Severe Cases On-site Treatment Cases Mild Cases Moderate Cases Severe Cases
By Region	North America  (U.S., Canada, Mexico) Europe  (France, Germany, UK, Italy, Spain, Rest Of Europe) Asia-Pacific  (Japan, China, India, Australia, South Korea, Rest Of Asia-Pacific) LAMEA  (Brazil, Turkey, Rest Of LAMEA)
Key Market Players	Huvepharma nv, Merck KGaA, Zoetis Inc., Ecolab Inc., Thermo Fisher Scientific Inc, Boehringer Ingelheim Gmbh, Neogen Corporation, Mileutis Ltd, Forte Healthcare Ltd., Armenta Ltd.

Analyst Review

According to the CXOs, the udder and mammary glands of dairy cows are affected by the dangerous medical condition known as mastitis. The illness has a significant negative impact on the worldwide dairy sector and can damage the tissues in animals that secrete milk. 

The bovine mastitis is mainly treated with antibiotics such as cephapirin, pirlimycin, and ceftiofur. In addition, it can be prevented by taking precautions such as maintaining hygiene and maintaining clean & dry housing area.

The factors such as increased in prevalence of bovine mastitis, advancements in veterinary healthcare industry, and rise in government initiatives drive the growth of bovine mastitis market. In addition, increase in demand for dairy products and rise in animal husbandry are expected to contribute in the growth of the bovine mastitis market.

Asia-Pacific is expected to witness the highest growth, in terms of revenue, owing to rise in incidences of bovine mastitis, the presence of key players for manufacturing & developing of advanced bovine mastitis, and growth in demand for dairy based products in the region.

However, the antibiotics resistance in animals and negative impact on human health by consuming such dairy products with traces of antibiotic metabolites can hamper market growth.

Author Name(s) : Prathmesh Santosh Bhasme | Roshan Deshmukh

Related Tags

• Animal Therapeutics
• Molecular Biology
• Animal Vaccines